^SAMPLE = GSM854888!Sample_title = SMZL#26_F-CTRL!Sample_geo_accession = GSM854888!Sample_status = Public on Jan 01 2014!Sample_submission_date = Dec 29 2011!Sample_last_update_date = Jan 01 2014!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = SMZL#26!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = gender: female!Sample_characteristics_ch1 = tissue: spleen tumor!Sample_characteristics_ch1 = disease: splenic marginal zone lymphoma!Sample_treatment_protocol_ch1 = Spleen tumour cell suspensions were collected before any specific chemotherapy or immunotherapy.!Sample_growth_protocol_ch1 = Spleen tumour cell suspensions were collected from patients that had undergone therapeutic splenectomy between 1999-2009 and were stored in the Biological Resource Centre of the Hospices Civils de Lyon, France.!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Total high quality genomic DNA was isolated according to the manufacturerâs instructions (Qiagen, Germantown, MD, USA) from frozen tumour spleen samples containing more than 60% of malignant B cells based on flow cytometry immunophenotyping or from control samples.!Sample_label_ch1 = Alexa-5!Sample_label_protocol_ch1 = Digested DNA products were labeled using random priming with either Alexa-5-dUTP or Alexa-3-dUTP using the Bioprime Total Genomic Labeling System (Invitrogen, California, USA) according to the manufacturerâs instructions.!Sample_source_name_ch2 = F-CTRL!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = gender: female!Sample_characteristics_ch2 = tissue: blood!Sample_characteristics_ch2 = disease: healthy!Sample_treatment_protocol_ch2 = Spleen tumour cell suspensions were collected before any specific chemotherapy or immunotherapy.!Sample_growth_protocol_ch2 = Spleen tumour cell suspensions were collected from patients that had undergone therapeutic splenectomy between 1999-2009 and were stored in the Biological Resource Centre of the Hospices Civils de Lyon, France.!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = Total high quality genomic DNA was isolated according to the manufacturerâs instructions (Qiagen, Germantown, MD, USA) from frozen tumour spleen samples containing more than 60% of malignant B cells based on flow cytometry immunophenotyping or from control samples.!Sample_label_ch2 = Alexa-3!Sample_label_protocol_ch2 = Digested DNA products were labeled using random priming with either Alexa-5-dUTP or Alexa-3-dUTP using the Bioprime Total Genomic Labeling System (Invitrogen, California, USA) according to the manufacturerâs instructions.!Sample_hyb_protocol = Each tumour samples (SMZL) were combined either with the female reference DNA or with the male reference DNA using a dye swap methodology to obtain a sex-matched and a sex-mismatch CGH profile. After denaturation, probes were pre-annealed with 50 Âµg of human Cot-1 DNA (Invitrogen, California, USA) and hybridization was performed at 65Â°C for 24 hours.!Sample_scan_protocol = The arrays were scanned on an Agilent G2565AA scanner.!Sample_description = Patient SMZL#26 versus female reference (dye-swap)!Sample_data_processing = Microarray images were analyzed using Agilent Feature Extraction Software (version 9.5.3.1) for background subtraction and normalization.!Sample_platform_id = GPL15068!Sample_contact_name = Laurent,,JALLADES!Sample_contact_email = laurent.jallades@chu-lyon.fr!Sample_contact_phone = 33(0)4 78 86 15 15!Sample_contact_fax = 33(0)4 78 86 33 40!Sample_contact_laboratory = Haematology!Sample_contact_institute = Hospices Civils de Lyon!Sample_contact_address = 165 Chemin du Grand Revoyet!Sample_contact_city = Pierre Benite!Sample_contact_zip/postal_code = 69495!Sample_contact_country = France!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM854nnn/GSM854888/suppl/GSM854888_252182510022_1.txt.gz!Sample_series_id = GSE34768!Sample_data_row_count = 45220#ID_REF = #VALUE = normalized log10 ratio Cy5/Cy3!sample_table_beginID_REF	VALUE1	7.666075733e-0022	-3.265610150e-0013	0.000000000e+0004	-5.132796547e-0015	0.000000000e+0006	0.000000000e+0007	-2.765579356e-0018	0.000000000e+0009	4.949546765e-00210	2.232587115e-00111	0.000000000e+00012	9.952156895e-00313	4.825518637e-00214	6.654454552e-00215	8.876316181e-00316	3.026811375e-00417	6.431238182e-00218	1.213306086e-00119	-6.391014055e-00220	-2.112000488e-002!sample_table_end